Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications

The molecular mechanisms of ferroptosis. Fe3+ is the predominant form of iron in circulation, which often combines with Trf and can be imported into cells via Trf1 located on cellular membrane. In addition, a part of iron can be imported into cells by SLC39A14 in the form of Fe2+. The Fe3+ within cells is firstly reduced to Fe2+ in the lysosome catalyzed by STEAP3, and then, ZIP 8/14 or DMT1 leads to the release of Fe2+ from the lysosome into LIP. Moreover, the Fe3+ in cells can also be stored in ferritin. NCOA4 can recognize ferritin and mediate ferritinophagy, reducing stored Fe3+ to Fe2+ and ultimately releasing Fe2+ into LIP. Furthermore, ferroportin is mainly in charge of the export of Fe2+ from cells. If the iron metabolism is disrupted, excessive Fe2+ will trigger lipid peroxidation and ferroptosis. PUFAs, as the most predominant substrates of lipid peroxidation, are firstly converted to PUFA-PLs by ACSL4 and LPCAT3. In the enzymatic pathway, LOXs oxidize PUFA-PLs to PUFA-PLOOH. In the non-enzymatic pathway, the excessive Fe2+ firstly reacts with ROS to generate OH∙ via Fenton reaction, which then abstracts hydrogen from PUFA-PL and forms PUFA-PL∙. Subsequently, O2 oxidizes PUFA-PL∙ to PUFA-PLOO∙, which abstracts hydrogen from the adjacent PUFA-PL and facilitates the propagation of lipid peroxidation. Ultimately, the overwhelming lipid peroxidation results in cellular membrane destruction and ferroptosis. ACSL4, acyl-CoA synthetase long-chain family member 4; NCOA4, nuclear receptor coactivator 4; LIP, labile iron pool; DMT1, divalent metal-iron transporter 1; LOXs, lipoxygenases; STEAP3, six transmembrane epithelial antigens of prostate 3; Trf, transferrin; Trf1, transferrin receptor 1; SLC39A14, solute carrier family 39 member 14; ZIP 8/14, zinc-iron regulatory protein family 8/14; PUFAs, polyunsaturated fatty acids; ROS, reactive oxygen species; LPCAT3, lysophosphatidylcholine acyltransferase 3. The symbol * means free radical.
Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications

Publication

Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications. (2023) Zilu Cheng, et al. Front Nutr. 2023;10:1090338. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates ACSL4 ACSL4 ncbigene_symbol ACSL4 2182
Homo sapiens Primates Fer- FER ncbigene_symbol FER 2241
Homo sapiens Primates PUFA PUFA ncbigene_synonym PUM3 9933
Homo sapiens Primates TF TF ncbigene_symbol TF 7018
Homo sapiens Primates Trfl TRF1 ncbigene_synonym TERF1 7013
Homo sapiens Primates LPCAT3 LPCAT3 ncbigene_symbol LPCAT3 10162
Homo sapiens Primates NCOA4 NCOA4 ncbigene_symbol NCOA4 8031
Homo sapiens Primates STEAP3 STEAP3 ncbigene_symbol STEAP3 55240
Homo sapiens Primates ZIP8 ZIP8 ncbigene_synonym SLC39A8 64116
Homo sapiens Primates ZIP8/14 ZIP14 ncbigene_synonym SLC39A14 23516
Homo sapiens Primates LIP LIP ncbigene_synonym SMG1 23049

Chemical mentions

Word Match MeSH Name ChEBI
Fe3+ Iron mesh:D007501 iron atom chebi:18248
PUFA PUFA-CoA PUFA Fatty Acids, Omega-3 mesh:D015525 omega-3 fatty acid chebi:25681
PUFA Fatty Acids, Omega-3 mesh:D015525 omega-3 fatty acid chebi:25681
PUFA-PLOO*--PUFA-PLOOH Fatty Acids, Omega-3 mesh:D015525 omega-3 fatty acid chebi:25681
OH hydroxide mesh:C031356 hydroxide ion chebi:16234
Fe2+OL Iron mesh:D007501 iron atom chebi:18248
Fe2+ Iron mesh:D007501 iron atom chebi:18248
Fe Iron mesh:D007501 iron atom chebi:18248
Fe2 Iron mesh:D007501 iron atom chebi:18248

Disease mentions

Word Match MeSH Name DOID
LIP Van der Woude syndrome mesh:C536528 Van der Woude syndrome doid:0060239